Sign In
Buy FSNUY
$11.30
+0.0300 (+0.266%)
At Close: Jun 22, 2026
Fresenius: The Signs Of A Significant Turnaround Are Getting Clearer And Clearer
01:53am, Saturday, 04'th Jan 2025
Fresenius is showing significant upside, with a 25% RoR since early 2024, driven by strong earnings growth and strategic execution. The company's turnaround is evident with improved EPS, reduced lever
Fresenius SE & Co. KGaA (FSNUF) Q3 2024 Earnings Call Transcript
06:38pm, Wednesday, 06'th Nov 2024
Fresenius SE & Co. KGaA (OTCPK:FSNUF) Q3 2024 Results Conference Call November 6, 2024 7:30 AM ET Company Participants Nick Stone - Vice President of Investor Relations Michael Sen - Chief Executive O
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
10:46am, Monday, 28'th Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Is Fresenius SE & Co. (FSNUY) Stock Undervalued Right Now?
10:43am, Thursday, 10'th Oct 2024
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Fresenius: Showing Signs Of Recovery, We Have Dawn
02:49am, Monday, 09'th Sep 2024
Fresenius is showing early signs of recovery, with improved profitability and a simplified structure, making it a promising investment despite past delays. The company's divestments and deleveraging e
Fresenius SE & Co. KGaA (FSNUF) Q2 2024 Earnings Call Transcript
03:04pm, Wednesday, 31'st Jul 2024
Fresenius SE & Co. KGaA (OTCPK:FSNUF) Q2 2024 Earnings Conference Call July 31, 2024 7:30 AM ET Company Participants Markus Georgi - Head of Investor Relations. Michael Sen - Chief Executive Officer S
Fresenius: It's Darkest Before The Dawn
07:30am, Tuesday, 07'th May 2024
Fresenius, a German healthcare company, has the potential for significant growth and a near-term turnaround. The company is in the midst of a restructuring and has met its revenue and earnings targets
Fresenius SE: Hoping For The Turnaround In 2024
05:52am, Wednesday, 28'th Feb 2024
Fresenius reported mediocre results and suspended the dividend this year, but management is optimistic for fiscal 2024. The company will focus on reducing debt levels in 2024 and the deconsolidation o
Fresenius SE & Co. KGaA (FSNUF) Q4 2023 Earnings Call Transcript
01:41pm, Wednesday, 21'st Feb 2024
Fresenius SE & Co. KGaA (FSNUF) Q4 2023 Earnings Call Transcript
Healthcare group Fresenius tops Q4 operating profit expectations
01:09am, Wednesday, 21'st Feb 2024
Fresenius reported a bigger-than-expected 13% jump in fourth-quarter operating profit on Wednesday, citing good earnings development across its businesses and progress in the operational turnaround at
Fresenius perfectly positioned to combat health inequality, says CEO
01:15pm, Monday, 15'th Jan 2024
Michael Sen, CEO at Fresenius, explains what the company is doing to help close the health care gap.
Fresenius SE & Co. KGaA (FSNUF) Q2 2023 Earnings Call Transcript
12:19pm, Sunday, 05'th Nov 2023
Fresenius SE & Co. KGaA (OTCPK:FSNUF) Q3 2023 Earnings Conference Call November 2, 2023 12:00 AM ET Company Participants Markus Georgi - Senior Vice President of Investor Relations Michael Sen - Chief
Fresenius to assess whether state aid impacts bonus, dividend payouts
03:04am, Saturday, 30'th Sep 2023
German healthcare group Fresenius said it was examining whether the state aid it received to help offset high energy costs at its hospitals business would bar it from making management bonus and divid
Is Fresenius SE & Co. (FSNUY) a Great Value Stock Right Now?
11:16am, Friday, 22'nd Sep 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Fresenius SE Probably Found Its Bottom
10:37am, Friday, 22'nd Sep 2023
Fresenius SE outperformed the S&P 500 in the last few quarters and could have found its temporary bottom. While the quarterly results are still not great, Fresenius Kabi is expected to grow with a hig
